Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015
Mycobacterium bovis bacillus Calmette-Guérin (BCG) is used as a vaccine to protect against disseminated tuberculosis (TB) and as a treatment for bladder cancer. We describe characteristics of US TB patients reported to the National Tuberculosis Surveillance System (NTSS) whose disease was attributed...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2019-03-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/25/3/18-0686_article |
| _version_ | 1828874922593615872 |
|---|---|
| author | Zimy Wansaula Jonathan M. Wortham Godwin Mindra Maryam B. Haddad Jorge L. Salinas David Ashkin Sapna B. Morris Gail B. Grant Smita Ghosh Adam J. Langer |
| author_facet | Zimy Wansaula Jonathan M. Wortham Godwin Mindra Maryam B. Haddad Jorge L. Salinas David Ashkin Sapna B. Morris Gail B. Grant Smita Ghosh Adam J. Langer |
| author_sort | Zimy Wansaula |
| collection | DOAJ |
| description | Mycobacterium bovis bacillus Calmette-Guérin (BCG) is used as a vaccine to protect against disseminated tuberculosis (TB) and as a treatment for bladder cancer. We describe characteristics of US TB patients reported to the National Tuberculosis Surveillance System (NTSS) whose disease was attributed to BCG. We identified 118 BCG cases and 91,065 TB cases reported to NTSS during 2004–2015. Most patients with BCG were US-born (86%), older (median age 75 years), and non-Hispanic white (81%). Only 17% of BCG cases had pulmonary involvement, in contrast with 84% of TB cases. Epidemiologic features of BCG cases differed from TB cases. Clinicians can use clinical history to discern probable BCG cases from TB cases, enabling optimal clinical management. Public health agencies can use this information to quickly identify probable BCG cases to avoid inappropriately reporting BCG cases to NTSS or expending resources on unnecessary public health interventions. |
| first_indexed | 2024-12-13T07:48:19Z |
| format | Article |
| id | doaj.art-f424a8f4b5154a09a4cbf7beb129b884 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-12-13T07:48:19Z |
| publishDate | 2019-03-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-f424a8f4b5154a09a4cbf7beb129b8842022-12-21T23:54:46ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592019-03-0125345145610.3201/eid2503.180686Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015Zimy WansaulaJonathan M. WorthamGodwin MindraMaryam B. HaddadJorge L. SalinasDavid AshkinSapna B. MorrisGail B. GrantSmita GhoshAdam J. LangerMycobacterium bovis bacillus Calmette-Guérin (BCG) is used as a vaccine to protect against disseminated tuberculosis (TB) and as a treatment for bladder cancer. We describe characteristics of US TB patients reported to the National Tuberculosis Surveillance System (NTSS) whose disease was attributed to BCG. We identified 118 BCG cases and 91,065 TB cases reported to NTSS during 2004–2015. Most patients with BCG were US-born (86%), older (median age 75 years), and non-Hispanic white (81%). Only 17% of BCG cases had pulmonary involvement, in contrast with 84% of TB cases. Epidemiologic features of BCG cases differed from TB cases. Clinicians can use clinical history to discern probable BCG cases from TB cases, enabling optimal clinical management. Public health agencies can use this information to quickly identify probable BCG cases to avoid inappropriately reporting BCG cases to NTSS or expending resources on unnecessary public health interventions.https://wwwnc.cdc.gov/eid/article/25/3/18-0686_articleBacillus Calmette-GuérinMycobacterium bovis–BCGtuberculosispublic health surveillanceTBtuberculosis and other mycobacteria |
| spellingShingle | Zimy Wansaula Jonathan M. Wortham Godwin Mindra Maryam B. Haddad Jorge L. Salinas David Ashkin Sapna B. Morris Gail B. Grant Smita Ghosh Adam J. Langer Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015 Emerging Infectious Diseases Bacillus Calmette-Guérin Mycobacterium bovis–BCG tuberculosis public health surveillance TB tuberculosis and other mycobacteria |
| title | Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015 |
| title_full | Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015 |
| title_fullStr | Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015 |
| title_full_unstemmed | Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015 |
| title_short | Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015 |
| title_sort | bacillus calmette guerin cases reported to the national tuberculosis surveillance system united states 2004 2015 |
| topic | Bacillus Calmette-Guérin Mycobacterium bovis–BCG tuberculosis public health surveillance TB tuberculosis and other mycobacteria |
| url | https://wwwnc.cdc.gov/eid/article/25/3/18-0686_article |
| work_keys_str_mv | AT zimywansaula bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT jonathanmwortham bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT godwinmindra bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT maryambhaddad bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT jorgelsalinas bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT davidashkin bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT sapnabmorris bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT gailbgrant bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT smitaghosh bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 AT adamjlanger bacilluscalmetteguerincasesreportedtothenationaltuberculosissurveillancesystemunitedstates20042015 |